USPH Stock Analysis: Buy, Sell, or Hold?
USPH - US Physical Therapy Inc
$62.51
-0.81 (-1.28%)
▼
5d:
-4.65%
30d:
+0.43%
90d:
-15.37%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When USPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: USPH appears deeply undervalued. Market expects -8.3% annual earnings decline despite 24% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: USPH appears deeply undervalued. Market expects -8.3% annual earnings decline despite 24% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$146.58
Based on 12.8% avg growth
INTRINSIC VALUE TODAY
$91.01
31.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USPH is currently trading at $62.51, which is considered slightly low relative to its 30-day fair value range of $61.80 to $64.67. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.3) compared to its historical average (23.7). Remarkably, the market is currently pricing in an annual earnings decline of 8.3% over the next few years. This pessimistic expectation contrasts with the company's recent 23.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, USPH is in a strong downtrend. The price is currently testing key support at $61.06. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $93.67 (+49.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, USPH is in a strong downtrend. The price is currently testing key support at $61.06. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $93.67 (+49.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$61.80 -
$64.67
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 49.8% below Wall St target ($93.67)
Trading Range Analysis
30-Day Trading Range
$61.80 -
$64.67
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$61.06
Resistance Level
$65.29
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.32
Wall Street Target
$93.67
(+49.8%)
Revenue Growth (YoY)
7.9%
Earnings Growth (YoY)
23.6%
Profit Margin
4.4%
Valuation Discount vs History
-8.3% cheaper
PE vs Historical
18.3 vs 23.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.3%
(market-implied from PE analysis)
1-Year Target
$57.32
(-8%)
2-Year Target
$52.56
(-16%)
3-Year Target
$48.20
(-23%)
3-Yr Target (if PE normalizes)
(PE: 18→24)
$62.37
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 21.6%)
$133.50
(+114%)
Base:
(SPY PE: 18.3, Growth: 21.6%)
$112.28
(+80%)
Bear:
(PE: 15.6, Growth: 21.6%)
$95.44
(+53%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Forward PE: 23.04 | Forward EPS (Implied): $2.71
Bull Case
$75.48
(+21%)
Analyst growth 15.0%, PE expands to 24.2
Base Case
$62.51
(0%)
Market implied 0.0%, PE stable at 23.0
Bear Case
$47.82
(-24%)
Severe decline -15.0%, PE contracts to 20.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.3 to 23.7
Stabilization Target:
$80.88
(+29.4%)
PE Expansion Potential:
+29.4%
Share & Embed Analysis
Last updated: June 23, 2026 9:01 AM ET
Data refreshes hourly during market hours. Next update: 10:01 AM
Data refreshes hourly during market hours. Next update: 10:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Graham D Reeve
SELL
662 shares
2026-03-11
Richard Binstein
SELL
3000 shares
2026-03-06
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 60 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
